SU1483948A1 - METHOD OF INACTIVATION OF VIRUS VICICULAR EXANTSA OF PIGS - Google Patents

METHOD OF INACTIVATION OF VIRUS VICICULAR EXANTSA OF PIGS

Info

Publication number
SU1483948A1
SU1483948A1 SU4305549/13A SU4305549A SU1483948A1 SU 1483948 A1 SU1483948 A1 SU 1483948A1 SU 4305549/13 A SU4305549/13 A SU 4305549/13A SU 4305549 A SU4305549 A SU 4305549A SU 1483948 A1 SU1483948 A1 SU 1483948A1
Authority
SU
USSR - Soviet Union
Prior art keywords
virus
pigs
inactivation
vicicular
exantsa
Prior art date
Application number
SU4305549/13A
Other languages
Russian (ru)
Inventor
Ж.А. Шажко
Ю.Ф. Швецов
А.И. Егорова
Р.Г. Костяновский
Г.К. Кадоркина
Р.К. Алекперов
Original Assignee
Всесоюзный научно-исследовательский ящурный институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всесоюзный научно-исследовательский ящурный институт filed Critical Всесоюзный научно-исследовательский ящурный институт
Priority to SU4305549/13A priority Critical patent/SU1483948A1/en
Application granted granted Critical
Publication of SU1483948A1 publication Critical patent/SU1483948A1/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Способ инактивации вируса везикулярной экзантемы свиней путем обработки вируссодержащей суспензии инактивирующим веществом, отличающийся тем, что, с целью повышения надежности инактивации и сохранения антигенности и иммуногенности инактивированного вируса, в качестве инактивирующего вещества используют этилениминометилморфолин, который добавляют в вируссодержащую суспензию до конечной концентрации 0,05 - 0,1% и полученную смесь инкубируют при 36 - 38C в течение 36 - 48 ч.The method of inactivating the virus of the vesicular exanthema of pigs by treating the virus-containing suspension with an inactivating substance, characterized in that, in order to increase the reliability of inactivation and preserve the antigenicity and immunogenicity of the inactivated virus, ethyleneimine methylmorpholine is used as the inactivating substance, which is added to the extract, and the extract is used. 0.1% and the mixture is incubated at 36 - 38C for 36 - 48 hours

SU4305549/13A 1987-09-11 1987-09-11 METHOD OF INACTIVATION OF VIRUS VICICULAR EXANTSA OF PIGS SU1483948A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4305549/13A SU1483948A1 (en) 1987-09-11 1987-09-11 METHOD OF INACTIVATION OF VIRUS VICICULAR EXANTSA OF PIGS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4305549/13A SU1483948A1 (en) 1987-09-11 1987-09-11 METHOD OF INACTIVATION OF VIRUS VICICULAR EXANTSA OF PIGS

Publications (1)

Publication Number Publication Date
SU1483948A1 true SU1483948A1 (en) 2000-03-20

Family

ID=60534596

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4305549/13A SU1483948A1 (en) 1987-09-11 1987-09-11 METHOD OF INACTIVATION OF VIRUS VICICULAR EXANTSA OF PIGS

Country Status (1)

Country Link
SU (1) SU1483948A1 (en)

Similar Documents

Publication Publication Date Title
DK0677114T3 (en) Recombinant swine fever virus
PT88590A (en) PROCESS FOR PREPARING AN INACTIVATED VACCINE COMPOSITION
DE3278344D1 (en) Stabilization of influenza virus vaccine
ATE61937T1 (en) ANTIGENIC PREPARATIONS AND ISOLATION OF SUCH PREPARATIONS.
ATE335810T1 (en) METHOD FOR INACTIVATION OF LIPID ENCLOSED VIRUSES
KR890000107A (en) Stabilized live virus vaccine and its preparation
ES379641A1 (en) Ethylethyleneimine as an inactivation agent
FI873083A0 (en) FOERFARANDE FOER ODLING AV BORDETELLA PERTUSSIS, KIKHOSTATOXOID OCH KIKHOSTAVACCIN.
SU1483948A1 (en) METHOD OF INACTIVATION OF VIRUS VICICULAR EXANTSA OF PIGS
KR870003790A (en) Heat treatment method of human thrombin
ATE81782T1 (en) PROCEDURE FOR PURIFICATION OF PROTEIC ANTIGENS FROM BORDETELLA BACTERIA FOR OBTAINING AN AZELLULAR VACCINE.
ATE45978T1 (en) STABILIZATION OF THE ACTIVITY OF PEROXIDASE IN SOLUTION.
DK52783D0 (en) VACCINE CONTAINING AN OZONE INACTIVATED MICRO-ORGANISM AND PROCEDURE FOR THE PREPARATION OF SUCH A VACCINE
KR890006254A (en) Method of Making Non-Specific Immune Inducers
NZ228232A (en) Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry
ATE201448T1 (en) VACCINES BASED ON STREPTOKINASE
SU1563237A1 (en) METHOD FOR INACTIVATION OF PIGS CALICIVIRUS
NL300073I1 (en) Vaccine.
RO76563A2 (en) PROCEDURE FOR STABILIZING AN ANTIHERPICAL VACCINE
DK569985A (en) VACCINE CONTAINING INACTIVATED INFECTIOUS BIRD SOURCE KIT virus
SU1565027A1 (en) Inactivating agent of the west nile virus
JPS5756431A (en) Inactivated vaccine for infectious disease caused by canine adenovirus type-2
JPS53109912A (en) Condensed tannin, inactivation of microorganism-originated toxic substance, and attenuation of vaccines using condensed tannin
GB1470508A (en) Method of treating poultry